Shots: Microbot Medical concludes its pivotal GLP pre-clinical study in porcine mo...
Shots: Daiichi Sankyo will receive $4B up front ($1.5B for ifinatamab deruxtecan d...
Shots: Monte Rosa Therapeutics will receive $50M up front and is eligible to recei...
Shots: SpliceBio will be eligible to receive up front, opt-in, and milestones of ~...
Shots: Synaffix will receive ~$740M incl. signature, target nomination & miles...
Shots: MediLink will receive $70M up front and is eligible to receive additional d...